$HSTM
HealthStream Inc

2015 Q1 Form 10-Q Financial Statement

#000119312515166239 Filed on May 01, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $47.16M $38.35M
YoY Change 22.96% 29.36%
Cost Of Revenue $20.19M $16.93M
YoY Change 19.3% 35.19%
Gross Profit $26.96M $21.42M
YoY Change 25.85% 25.1%
Gross Profit Margin 57.18% 55.86%
Selling, General & Admin $14.27M $12.18M
YoY Change 17.2% 28.59%
% of Gross Profit 52.94% 56.85%
Research & Development $4.646M $3.546M
YoY Change 31.02% 36.07%
% of Gross Profit 17.23% 16.55%
Depreciation & Amortization $3.253M $2.401M
YoY Change 35.49% 27.99%
% of Gross Profit 12.06% 11.21%
Operating Expenses $18.92M $15.73M
YoY Change 20.32% 30.21%
Operating Profit $4.790M $3.298M
YoY Change 45.24% 3.94%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $9.000K $45.00K
YoY Change -80.0% -4.26%
Pretax Income $4.799M $3.343M
YoY Change 43.55% 3.82%
Income Tax $2.077M $1.395M
% Of Pretax Income 43.28% 41.73%
Net Earnings $2.722M $1.948M
YoY Change 39.73% 0.36%
Net Earnings / Revenue 5.77% 5.08%
Basic Earnings Per Share $0.10 $0.07
Diluted Earnings Per Share $0.10 $0.07
COMMON SHARES
Basic Shares Outstanding 27.70M shares 27.45M shares
Diluted Shares Outstanding 28.07M shares 27.91M shares

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $64.40M $102.0M
YoY Change -36.86% 6.69%
Cash & Equivalents $34.76M $59.05M
Short-Term Investments $29.60M $43.00M
Other Short-Term Assets $5.780M $3.231M
YoY Change 78.89% -44.29%
Inventory
Prepaid Expenses
Receivables $35.79M $32.07M
Other Receivables $0.00 $0.00
Total Short-Term Assets $124.7M $150.3M
YoY Change -16.98% 19.91%
LONG-TERM ASSETS
Property, Plant & Equipment $10.82M $9.189M
YoY Change 17.78% 17.81%
Goodwill $88.77M $42.75M
YoY Change 107.64%
Intangibles
YoY Change
Long-Term Investments $2.800M
YoY Change
Other Assets $2.315M $995.0K
YoY Change 132.66% 65.83%
Total Long-Term Assets $174.7M $80.71M
YoY Change 116.47% 43.1%
TOTAL ASSETS
Total Short-Term Assets $124.7M $150.3M
Total Long-Term Assets $174.7M $80.71M
Total Assets $299.4M $231.0M
YoY Change 29.65% 27.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.904M $2.914M
YoY Change -34.66% 124.15%
Accrued Expenses $9.728M $6.948M
YoY Change 40.01% -27.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $88.30M $69.72M
YoY Change 26.66% 77.4%
LONG-TERM LIABILITIES
Long-Term Debt $28.00M $0.00
YoY Change
Other Long-Term Liabilities $2.691M $750.0K
YoY Change 258.8% 7.14%
Total Long-Term Liabilities $30.69M $750.0K
YoY Change 3992.13% 7.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $88.30M $69.72M
Total Long-Term Liabilities $30.69M $750.0K
Total Liabilities $119.0M $70.47M
YoY Change 68.86% 51.55%
SHAREHOLDERS EQUITY
Retained Earnings -$4.308M -$15.48M
YoY Change -72.16%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $171.0M $154.3M
YoY Change
Total Liabilities & Shareholders Equity $299.4M $231.0M
YoY Change 29.65% 27.11%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income $2.722M $1.948M
YoY Change 39.73% 0.36%
Depreciation, Depletion And Amortization $3.253M $2.401M
YoY Change 35.49% 27.99%
Cash From Operating Activities $9.010M $9.190M
YoY Change -1.96% 138.08%
INVESTING ACTIVITIES
Capital Expenditures $2.313M $1.104M
YoY Change 109.51% 48.39%
Acquisitions $88.08M $12.50M
YoY Change 604.54% 6806.63%
Other Investing Activities -$79.92M -$7.410M
YoY Change 978.54% 2750.0%
Cash From Investing Activities -$84.25M -$9.980M
YoY Change 744.19% 382.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.02M 290.0K
YoY Change 9562.07% -60.81%
NET CHANGE
Cash From Operating Activities 9.010M 9.190M
Cash From Investing Activities -84.25M -9.980M
Cash From Financing Activities 28.02M 290.0K
Net Change In Cash -47.22M -500.0K
YoY Change 9344.0% -119.76%
FREE CASH FLOW
Cash From Operating Activities $9.010M $9.190M
Capital Expenditures $2.313M $1.104M
Free Cash Flow $6.697M $8.086M
YoY Change -17.18% 159.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27784427 shares
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59045000
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27784000 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27784000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2015Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3855000
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27238000
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
88304000
CY2015Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
175369000
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1904000
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4308000
CY2015Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5547000
CY2015Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
19387000
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9728000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
171045000
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2691000
CY2015Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
28000000
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
299442000
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14636000
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
66531000
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1660000
CY2015Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
8481000
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
320000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34764000
CY2015Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4621000
CY2015Q1 us-gaap Goodwill
Goodwill
88766000
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10823000
CY2015Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
29611000
CY2015Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
56593000
CY2015Q1 us-gaap Prepaid Royalties
PrepaidRoyalties
14975000
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38061000
CY2015Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
13456000
CY2015Q1 us-gaap Acquired Finite Lived Intangible Asset Residual Value
AcquiredFiniteLivedIntangibleAssetResidualValue
42600000
CY2015Q1 us-gaap Assets
Assets
299442000
CY2015Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2575000
CY2015Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
2753000
CY2015Q1 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1242000
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
35789000
CY2015Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5877000
CY2015Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
27563000
CY2015Q1 us-gaap Other Assets Current
OtherAssetsCurrent
5780000
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2315000
CY2015Q1 us-gaap Assets Current
AssetsCurrent
124736000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59537000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27677000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27677000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2014Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3657000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26105000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
77259000
CY2014Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
174926000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4753000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
167859000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2649000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
257262000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7030000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5838000
CY2014Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
18114000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7224000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13834000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
53716000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2311000
CY2014Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
9255000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
331000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81995000
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4554000
CY2014Q4 us-gaap Goodwill
Goodwill
41914000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9442000
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
38973000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14795000
CY2014Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
13030000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35547000
CY2014Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
12706000
CY2014Q4 us-gaap Assets
Assets
257262000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
354000
CY2014Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1757000
CY2014Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1678000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33167000
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5860000
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
25133000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5414000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2037000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
174611000
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.417 pure
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
453000 shares
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
9194000
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27906000 shares
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
165000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27453000 shares
CY2014Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
13176000
CY2014Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
2667000
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000
CY2014Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5107000
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
38350000
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-140000
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-26000
CY2014Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12501000
CY2014Q1 us-gaap Payments For Software
PaymentsForSoftware
1464000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3298000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1956000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3343000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
45000
CY2014Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
250000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1104000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
1948000
CY2014Q1 us-gaap Stock Issued1
StockIssued1
2246000
CY2014Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
5000
CY2014Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
152000
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
384000
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1395000
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2401000
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8599000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3546000
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6947000
CY2014Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
376000
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
70000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-492000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1395000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
292000
CY2014Q1 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
16926000
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1447000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9978000
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
449000
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
35052000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5232000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
604000
CY2014Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
18517000
CY2014Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
2472000
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
CY2015Q1 dei Trading Symbol
TradingSymbol
HSTM
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.433 pure
CY2015Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
365000 shares
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
9007000
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28068000 shares
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2015Q1 us-gaap Line Of Credit Facility Covenant Terms
LineOfCreditFacilityCovenantTerms
A funded debt leverage ratio (consolidated debt/consolidated EBITDA) of not greater than 3.0 to 1.0 and an interest coverage ratio (consolidated EBITDA/consolidated interest expense) of not less than 3.0 to 1.0.
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001095565
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27703000 shares
CY2015Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
7000
CY2015Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
1945000
CY2015Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
34000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21000
CY2015Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1049000
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
47156000
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-278000
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
277000
CY2015Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
88075000
CY2015Q1 us-gaap Payments For Software
PaymentsForSoftware
2023000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4790000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2743000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4799000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2015Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2313000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
2722000
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
409000
CY2015Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
19000
CY2015Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
213000
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
21000
CY2015Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
409000
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3253000
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6881000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4646000
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7347000
CY2015Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
225000
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-47231000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2077000
CY2015Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
46852000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
28015000
CY2015Q1 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
20193000
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
25000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-84253000
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
247000
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
42366000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6927000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2849000
CY2015Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
28000000
CY2015Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
9165000
CY2015Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-774000
CY2015Q1 hstm Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 Incentive_Plan

Files In Submission

Name View Source Status
0001193125-15-166239-index-headers.html Edgar Link pending
0001193125-15-166239-index.html Edgar Link pending
0001193125-15-166239.txt Edgar Link pending
0001193125-15-166239-xbrl.zip Edgar Link pending
d903600d10q.htm Edgar Link pending
d903600dex311.htm Edgar Link pending
d903600dex312.htm Edgar Link pending
d903600dex321.htm Edgar Link pending
d903600dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hstm-20150331.xml Edgar Link completed
hstm-20150331.xsd Edgar Link pending
hstm-20150331_cal.xml Edgar Link unprocessable
hstm-20150331_def.xml Edgar Link unprocessable
hstm-20150331_lab.xml Edgar Link unprocessable
hstm-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending